Literature DB >> 12027580

Critical determinants of metastasis.

Isaiah J Fidler1.   

Abstract

The major cause of death from cancer is due to metastases that are resistant to conventional therapies. Several reasons account for the failure to treat metastases. First, neoplasms are biologically heterogeneous and contain subpopulations of cells with different angiogenic, invasive, and metastatic properties. Second, the process of metastasis selects for a small subpopulation of cells that preexist within a parental neoplasm. Third, and perhaps the greatest obstacle for therapy, is that the outcome of metastasis depends on multiple interactions ('cross-talk') of metastatic cells with homeostatic mechanisms which the tumor cells usurp. Most recent data demonstrate that the organ microenvironment can influence the growth, invasion, and response of metastases to chemotherapy. Therapy of metastasis should therefore be targeted against both the metastatic tumor cells and the homeostatic factors that promote metastasis. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027580     DOI: 10.1006/scbi.2001.0416

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  123 in total

1.  Soiling the seed: microenvironment and epithelial mesenchymal plasticity.

Authors:  Izhak Haviv; Erik W Thompson
Journal:  Cancer Microenviron       Date:  2012-04

Review 2.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

3.  Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.

Authors:  Lindsay J Talbot; Syamal D Bhattacharya; Paul C Kuo
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

4.  Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.

Authors:  Yoshinaga Okugawa; Yuji Toiyama; Shusuke Toden; Hiroki Mitoma; Takeshi Nagasaka; Koji Tanaka; Yasuhiro Inoue; Masato Kusunoki; C Richard Boland; Ajay Goel
Journal:  Gut       Date:  2015-10-15       Impact factor: 23.059

5.  The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma.

Authors:  Brigitte Strahm; Adam D Durbin; Elizabeth Sexsmith; David Malkin
Journal:  Clin Exp Metastasis       Date:  2007-09-01       Impact factor: 5.150

6.  GRK3 is essential for metastatic cells and promotes prostate tumor progression.

Authors:  Wenliang Li; Nanping Ai; Suming Wang; Nandita Bhattacharya; Vladimir Vrbanac; Michael Collins; Sabina Signoretti; Yanhui Hu; Frederick M Boyce; Karsten Gravdal; Ole J Halvorsen; Hawa Nalwoga; Lars A Akslen; Ed Harlow; Randolph S Watnick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

7.  Tumor microenvironment regulates metastasis and metastasis genes of mouse MMTV-PymT mammary cancer cells in vivo.

Authors:  J L Werbeck; N K Thudi; C K Martin; C Premanandan; L Yu; M C Ostrowksi; T J Rosol
Journal:  Vet Pathol       Date:  2013-10-03       Impact factor: 2.221

8.  CXCL5 overexpression is associated with late stage gastric cancer.

Authors:  Jeong Youp Park; Kyung Hwa Park; Seungmin Bang; Myoung Hwan Kim; Ji-Eun Lee; Jingu Gang; Sang Seok Koh; Si Young Song
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-04       Impact factor: 4.553

9.  Midkine is highly expressed in neuroblastoma tissues.

Authors:  Henning C Fiegel; Jussuf T Kaifi; Robin Wachowiak; Alexander Quaas; Kuniaki Aridome; Keiko Ichihara-Tanaka; Takashi Muramatsu; Roman Metzger; Jakob R Izbicki; Rudolf Erttmann; Dietrich Kluth; Holger Till
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

10.  Gene profiles between non-invasive and invasive colon cancer using laser microdissection and polypeptide analysis.

Authors:  Jin-Shui Zhu; Hua Guo; Ming-Quan Song; Guo-Qiang Chen; Qun Sun; Qiang Zhang
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.